Doctors in Gabon are testing a new single-dose malaria treatment that could help combat growing resistance to existing drugs. Led by Dr. Ghyslain Mombo-Ngoma at the Medical Research Centre of Lambaréné, the team combined four widely used anti-malarial compounds, sulfadoxine, pyrimethamine, artesunate, and pyronaridine into a one-time treatment. The regimen cleared malaria parasites in 93% …
